Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on corporate actions and treasury share transactions for the month of March 2016, filed on April 8, 2016. The document is a compliance report under Article 11 of CVM Instruction # 358/2002, detailing changes in the company's outstanding shares held in treasury and American Depositary Receipts (ADRs).
Key Financial Metrics and Treasury Activity
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or debt levels. Instead, it details the following treasury and equity movements:
- Treasury Shares (Common):
- Initial Balance: 31,465,305 shares (0.2002% of total).
- Final Balance: 23,090,201 shares (0.1469% of total).
- Net Change: Decrease of 8,375,104 shares.
- ADRs:
- Initial and Final Balance: 0 shares.
- Activity involved conversions and exercises that netted to zero holdings.
- Transaction Volumes (Common Shares):
- Total Conversions (In): 2,785,132 shares.
- Total Sales/Reductions: 5,800,211 shares (Volume: R$ 27,250,823.14).
- Total Purchases/Acquisitions: 210,239 shares (Volume: R$ 3,936,277.84).
Material Changes Versus Prior Period
The filing does not provide comparative financial data against a prior period. The primary material change reported is the significant reduction in the company's treasury share holdings, decreasing from approximately 31.5 million to 23.1 million shares during March 2016. This reduction was driven by share exercises, bonus allocations, and deferred share transactions.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is strictly a transactional report of securities movements.
Key Facts for Investor Verification
- Verify the impact of the 8.4 million share reduction in treasury on the company's total outstanding share count and earnings per share (EPS) calculations.
- Confirm the specific terms of the "Plan of Shares Acquisition" and "Private Acquisition" transactions totaling R$ 3.9 million.
- Note that the filing covers March 2016 activity, despite the metadata reference to a June 30, 2016 period; no data for Q2 2016 is present in this document.
- Understand that this document does not contain financial statements (Revenue, EBITDA, Net Income) and should not be used for fundamental valuation without accompanying 20-F or quarterly reports.